Entity Name: | DUPAGE MEDICAL TECHNOLOGY, INC. |
Jurisdiction: | Illinois |
Entity Type: | Corporation - Domestic BCA |
Status: | Goodstanding |
Date Formed: | 26 Oct 2012 |
Company Number: | CORP_68656176 |
File Number: | 68656176 |
Type of Business: | All Inclusive Purpose |
Place of Formation: | ILLINOIS |
Unique Entity ID | Expiration Date | Physical Address | Mailing Address | |||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PBQ3ANGJVJ15 | 2024-12-03 | 1316 S RIDGE RD, WILLOWBROOK, IL, 60527, 1896, USA | 2201 W CAMPBELL PARK DRIVE, SUITE 316, CHICAGO, IL, 60612, USA | |||||||||||||||||||||||||||||||||||||||||||||||||
|
Congressional District | 06 |
State/Country of Incorporation | IL, USA |
Activation Date | 2023-12-06 |
Initial Registration Date | 2015-03-05 |
Entity Start Date | 2012-10-26 |
Fiscal Year End Close Date | Dec 31 |
Service Classifications
NAICS Codes | 541713, 541714 |
Points of Contacts
Electronic Business | |
---|---|
Title | PRIMARY POC |
Name | ALEKSANDRA STOJANOVIC |
Role | CHIEF OPERATING OFFICER |
Address | 2201 W. CAMPBELL PARK DRIVE, SUITE 316, CHICAGO, IL, 60612, USA |
Title | ALTERNATE POC |
Name | XIAOPING DU |
Role | DR. |
Address | 1316 S RIDGE ROAD, WILLOWBROOK, IL, 60527, USA |
Government Business | |
---|---|
Title | PRIMARY POC |
Name | ALEKSANDRA STOJANOVIC |
Address | 2201 W. CAMPBELL PARK DRIVE, SUITE 316, CHICAGO, IL, 60612, USA |
Past Performance | Information not Available |
---|
Name and Address | Role | Appointment Date |
---|---|---|
XIAOPING DU, 2201 W CAMPBELL PARK DR SUITE 316, CHICAGO, 60612, COOK-NOT IN CITY OF CHICAGO | Agent | 2023-02-07 |
Name and Address | Role |
---|---|
XIAOPING DU, 1316 S RIDGE ROAD, WILLOWBROOK, IL 60527 | President |
Name and Address | Role |
---|---|
XIAOPING DU, 1316 S RIDGE ROAD, WILLOWBROOK, IL 60527 | Secretary |
Class | Series | Voting Rights | Authorized Shares | Issued Shares | Par Value |
---|---|---|---|---|---|
COMMON | No data | Voting Rights | 16667 | 4433000 | 1 |
Contract Type | Award or IDV Flag | PIID | Start Date | Current End Date | Potential End Date | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
DEFINITIVE CONTRACT | AWARD | HHSN268201700002C | 2016-11-15 | 2020-02-14 | 2020-02-14 | |||||||||||||||||||||||||
|
Obligated Amount | 1958172.98 |
Current Award Amount | 1958172.98 |
Potential Award Amount | 1958172.98 |
Description
Title | DEVELOPING AN INHIBITOR OF INTEGRIN OUTSIDE-IN SIGNALING AS A NEW GENERATION OF ANTI-THROMBOTIC DRUG - VITA 2 |
NAICS Code | 541712: RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) |
Product and Service Codes | AN11: HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
Recipient Details
Recipient | DUPAGE MEDICAL TECHNOLOGY INC |
UEI | PBQ3ANGJVJ15 |
Recipient Address | UNITED STATES, 1316 RIDGE RD, WILLOWBROOK, DUPAGE, ILLINOIS, 605271896 |
Date of last update: 27 Jan 2025